Recent developments in pertussis research

References

1. Redhead K, Hill T, Chart H. Interaction of lactoferrin and transferrins with the outer membrane of Bordetella pertussis. J Gen Microbiol 1987; 133:891–898
   [Google Scholar]
2. Tamura M, Nogimori K, Murai S. et al. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 1982; 21:5516–5522
   [Google Scholar]
3. Witvliet MH, Burns DL, Brennan MJ, Poolman JT, Manclark CR. Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun 1989; 57:3324–3330
   [Google Scholar]
4. Sato H, Ito A, Chiba J, Sato Y. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun 1984; 46:422–428
   [Google Scholar]
5. Sato H, Sato Y, Ito A, Ohishi I. Effect of monoclonal antibody to pertussis toxin on toxin activity. Infect Immun 1987; 55:909–915
   [Google Scholar]
6. Sato H, Sato Y. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect Immun 1984; 46:415–421
   [Google Scholar]
7. Steinman L, Weiss A, Adelman N. et al. Pertussis toxin is required for pertussis vaccine encephalopathy. Proc Natl Acad Sci USA 1985; 82:8733–8736
   [Google Scholar]
8. Nicosia A, Perugini M, Franzini C. et al. Cloning and sequencing of the pertussis toxin genes: Operon structure and gene duplication. Proc Natl Acad Sci USA 1986; 83:4631–4635
   [Google Scholar]
9. Pizza M, Bartolini A, Prugnola A, Silvestri S, Rappuoli R. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. Proc Natl Acad Sci USA 1988; 85:7521–7525
   [Google Scholar]
10. Pizza M, Covacci A, Bartolini A. et al. Mutants of pertussis toxin suitable for vaccine development. Science 1989; 246:497–500
    [Google Scholar]
11. De Magistris MT, Romano M, Bartolini A, Rappuoli R, Tagliabue A. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med 1989; 169:1519–1532
    [Google Scholar]
12. Gray LS, Huber KS, Gray MC, Hewlett EL, Engelhard VH. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J Immunol 1989; 142:1631–1638
    [Google Scholar]
13. Sekura RD, Zhang YL. Pertussis toxin: structural elements involved in the interaction with cells. Sekura RD, Moss J, Vaughan M. eds Pertussis toxin Orlando: Academic Press; 198545–64
    [Google Scholar]
14. Holt LB. The pathology and immunology of Bordetella pertussis infection. J Med Microbiol 1972; 5:407–424
    [Google Scholar]
15. Sato Y, Izumiya K, Sato H, Cowell JL, Manclark CR. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun 1981; 31:1223–1231
    [Google Scholar]
16. Gorringe AR, Ashworth LAE, Irons LI, Robinson A. Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells. FEMS Microbiol Lett 1985; 26:5–9
    [Google Scholar]
17. Brownlie RM, Coote JG, Parton R, Schultz JE, Rogel A, Hanski E. Cloning of the adenylate cyclase genetic determinant of Bordetella pertussis and its expression in Escherichia coli and B. pertussis. Microb Pathog 1988; 4:335–344
    [Google Scholar]
18. Rogel A, Farfel Z, Goldschmidt S, Shiloach J, Hanski E. Bordetella pertussis adenylate cyclase. Identification of multiple forms of the enzyme by antibodies. J Biol Chem 1988; 263:13310–13316
    [Google Scholar]
19. Rogel A, Schultz JE, Brownlie RM, Coote JG, Parton R, Hanski E. Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme. EMBO J 1989; 8:2755–2760
    [Google Scholar]
20. Cookson BT, Tyler AN, Goldman E. Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis. Biochemistry 1989; 28:1744–1749
    [Google Scholar]
21. Goldman WE, Klapper DG, Baseman JB. Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun 1982; 36:782–794
    [Google Scholar]
22. Goldman WE, Herwaldt LA. Bordetella pertussis tracheal cytotoxin. Dev Biol Stand 1985; 61:103–111
    [Google Scholar]
23. Goldman WE, Cookson BT. Structure and functions of the Bordetella tracheal cytotoxin. Tokai J Exp Clin Med 1988; 13:Suppl187–191
    [Google Scholar]
24. Folkening WJ, Nogami W, Martin SA, Rosenthal RS. Structure of Bordetella pertussis peptidoglycan. J Bacterial 1987; 169:4223–4227
    [Google Scholar]
25. Novotny P, Chubb AP, Cownley K, Montaraz JA, Beesley JE. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor. Dev Biol Stand 1985; 61:27–41
    [Google Scholar]
26. Munoz JJ, Peacock MG. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species. Microbiol Immunol 1989; 33:341–355
    [Google Scholar]
27. Svoboda M, Hannecart-Pokorni E, Borremans M, Christophe J. Rapid purification of Bordetella pertussis toxin by alternating affinity and hydrophobic chromatography. Anal Biochem 1986; 159:402–411
    [Google Scholar]
28. Bartolini A, Pizza M, Gross R. et al. Engineering bacterial toxin for the development of new vaccine against pertussis. Tokai J Exp Clin Med 1988; 13:Suppl217–222
    [Google Scholar]
29. Mussett MV, Sheffield F. A collaborative investigation of methods proposed for the potency assay of adsorbed diphtheria and tetanus toxoids in the European Pharmacopoeia. J Biol Stand 1973; 1:259–283
    [Google Scholar]
30. McPheat WL, McNally T. Isolation of a repeated DNA sequence from Bordetella pertussis. J Gen Microbiol 1987; 133:323–330
    [Google Scholar]
31. McPheat WL, Hanson JH, Livey I, Robertson JS. Analysis of separate isolates of Bordetella pertussis repeated DNA sequences. J Gett Microbiol 1989; 135:1515–1520
    [Google Scholar]
32. Tenover FC. Diagnostic deoxyribonucleic acid probes for infectious diseases. Clin Microbiol Rev 1988; 1:82–101
    [Google Scholar]
33. Preston NW. Pertussis today. Wardlaw AC, Parton R. eds Pathogenesis and immunity in pertussis. Chichester: John Wiley; 19881–18
    [Google Scholar]
34. Maxwell S, Preston NW. Surveillance of pertussis in Britain: 1985-88. Communicable Disease Report 89/34 London: Public Health Laboratory Service; 19893–4
    [Google Scholar]
35. Swansea Research Unit Royal College of General Practitioners. Effect of low pertussis vaccination uptake on a large community. Br Med J19M 282:23–26
    [Google Scholar]